Checkpoint Toxicity

Recommendations

Info

About the CourseTwelve immunotherapy agents have been approved sine 2011 in a wide variety of cancers.Immune checkpoint blockade leads to a new spectrum of dysimmune toxicity requiringcollaboration between oncologists, providers, and specialists to improve the understandingof the mechanism, diagnosis, and management of immune-related adverse events (irAEs).The goal of the program is to bring together a multidisciplinary group of clinicians to shareexpertise and improve the care of patients receiving immune checkpoint inhibitor therapies.Specialists in dermatology, endocrinology, gastroenterology, oncology, internal medicine,rheumatology/immunology, nurses, nurse practitioners, physician assistants and residents/fellows are invited to attend.Learning ObjectivesAs a result of attending the course, the participant will be able to:• Describe the mechanism of action associated with checkpoint inhibitor therapies.• Identify the spectrum of immune-related adverse events that can occur with immunecheckpoint inhibitor therapies.• Implement assessment criteria, diagnostic testing, and interventions to improve earlyidentification and management of immune-related AEs.• Recognize the importance and necessity of the multidisciplinary approach in treatmentof immune-related adverse events.Program LocationInterContinental Hotel & Conference Center9801 Carnegie AvenueCleveland, OH 44106Hotel Information and ReservationsA block of rooms has been reserved at the InterContinental Hotel & Conference Center until5:00 pm ET, February 4, 2020. Make your reservation by calling 855.765.8709. Pleaseidentify yourself as being with the Cleveland Clinic Immunotherapy conference for a specialrate of $189 plus tax.ParkingParking is available in the E 100th Street visitor’s parking garage.Faculty DisclosureThe Cleveland Clinic Foundation Center for Continuing Education has implemented a policy tocomply with the current Accreditation Council for Continuing Medical Education Standards forCommercial Support requiring resolution of all faculty conflicts of interest. Faculty declaringa relevant commercial interest will be identified in the activity syllabus.AccreditationThe Cleveland Clinic Foundation Center for Continuing Education is accredited by theAccreditation Council for Continuing Medical Education (ACCME) to provide continuingmedical education for physicians.The Cleveland Clinic Foundation Center for Continuing Education designates this live activityfor a maximum of 6.25 AMA PRA Category 1 Credits. Physicians should claim only thecredit commensurate with the extent of their participation in the activity.Participants claiming CME credit from this activity may submit the credit hours to theAmerican Osteopathic Association for Category 2 credit.The Ohio Board of Nursing will accept at face value the number of contact hours awarded foran educational activity that has been approved for CE by a nationally accredited system ofCE approval.
Nurses are able to obtain CE that has been approved or provided by a nationally recognizedaccreditation system of continuing education.Examples include:• The American Nurses Credentialing Center (ANCC)• The Accreditation Council for Continuing Medical Education (ACCME)• The International Association for Continuing Education and Training (IACET)InformationFor further information about this activity, contact Sheryl Krall atLocal: 216.444.7924Toll Free: 800.223.2273 x47924Email: kralls2@ccf.orgDeadline for Registration & CancellationRegister at www.ccfcme.org/toxicitymgmt. The deadline for registration is 5:00 pm(EST), Wednesday, March 4, 2020. A request for refund must be received in writing byFebruary 26, 2020. No refunds will be given after March 6, 2020. A $50 cancellation fee willbe deducted from the refund for cancellations after February 26, 2020. For questions aboutregistrations, please call 216.448.8710 or email cmeregistration@ccf.org.FacultyCourse DirectorsPauline Funchain, MDDepartment of Hematology/Medical OncologyCleveland ClinicPlanning CommitteeCassandra M Calabrese, DODepartment of Rheumatologic andImmunologic DiseaseCleveland ClinicCleveland Clinic FacultyJoshua Arbesman, MDDepartment of DermatologyLeonard Calabrese, DODepartment of Rheumatologic andImmunologic DiseaseBassam Estfan, MDDepartment of Hematology/Medical OncologyElizabeth Kirchner, CNPDepartment of Rheumatologic andImmunologic DiseaseMarisa McGinley, DOMellen CenterRohit Moudgil, MD, PhDDepartment of Cardiovascular MedicineChristian Nasr, MDDepartment of Endocrinology, Diabetes andMetabolismManuel Lessa Ribeiro Neto, MDDepartment of Pulmonary MedicineLaura S. Wood, RN, MSN, OCNDepartment of Hematology/Medical OncologyCleveland ClinicInvited FacultyJason Bischof, MDDepartment of Emergency MedicineThe Ohio State University Wexner MedicalCenterColumbus, OHMoshe Ornstein, MD, MADepartment of Hematology/Medical OncologyJessica Philpott, MD, PhDDepartment of Gastroenterology, Hepatology,and NutritionCarlos Romero-Marrero, MDDepartment of Gastroenterology, Hepatology,and NutritionJung-Min Song, CNSDepartment of Hematology/Medical OncologyCarolyn Stanek, RNDepartment of Hematology/Medical OncologyJames Stevenson, MDDepartment of Hematology/Medical OncologyArthi Venkat, MDDepartment of Ophthalmology
Page 1: Management of CheckpointInhibitor-R
Page 5 and 6: RegistrationManagement of Checkpoin

Checkpoint Toxicity

Create successful ePaper yourself

Delete template?

Save as template?